𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B

✍ Scribed by Elif Doyuk Kartal; Saygin Nayman Alpat; Ilhan Ozgunes; Gaye Usluer


Book ID
105639221
Publisher
Springer Healthcare Communications
Year
2007
Tongue
English
Weight
253 KB
Volume
24
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cost effectiveness of interferon α2b com
✍ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated

High doses of recombinant α-interferon o
✍ Federico Sáez-royuela; Juan Carlos Porres; Alberto Moreno; Inmaculada Castillo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten

Treatment of chronic type B hepatitis wi
✍ Werner-J. Mayet; Georg Hess; Guido Gerken; Siegbert Rossol; Rita Voth; Michael M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo